- Home
- APLT vs LSF Comparison
APLT vs LSF Comparison
Compare APLT & LSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- LSF
- Stock Information
- Founded
- APLT 2016
- LSF 2015
- Country
- APLT United States
- LSF United States
- Employees
- APLT N/A
- LSF N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- LSF Packaged Foods
- Sector
- APLT Health Care
- LSF Consumer Staples
- Exchange
- APLT Nasdaq
- LSF Nasdaq
- Market Cap
- APLT 69.0M
- LSF 65.5M
- IPO Year
- APLT 2019
- LSF 2020
- Fundamental
- Price
- APLT $0.51
- LSF $5.97
- Analyst Decision
- APLT Buy
- LSF Strong Buy
- Analyst Count
- APLT 6
- LSF 2
- Target Price
- APLT $6.10
- LSF $12.00
- AVG Volume (30 Days)
- APLT 893.4K
- LSF 53.5K
- Earning Date
- APLT 08-13-2025
- LSF 08-06-2025
- Dividend Yield
- APLT N/A
- LSF N/A
- EPS Growth
- APLT N/A
- LSF N/A
- EPS
- APLT N/A
- LSF N/A
- Revenue
- APLT $121,000.00
- LSF $47,027,546.00
- Revenue This Year
- APLT $415.60
- LSF $22.13
- Revenue Next Year
- APLT $1,323.96
- LSF $20.71
- P/E Ratio
- APLT N/A
- LSF N/A
- Revenue Growth
- APLT N/A
- LSF 22.79
- 52 Week Low
- APLT $0.30
- LSF $3.40
- 52 Week High
- APLT $10.62
- LSF $10.90
- Technical
- Relative Strength Index (RSI)
- APLT 61.88
- LSF 44.37
- Support Level
- APLT $0.47
- LSF $5.55
- Resistance Level
- APLT $0.53
- LSF $6.71
- Average True Range (ATR)
- APLT 0.03
- LSF 0.44
- MACD
- APLT 0.00
- LSF -0.06
- Stochastic Oscillator
- APLT 83.33
- LSF 26.42
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About LSF Laird Superfood Inc.
Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.